INMB – inmune bio inc. - common stock (US:NASDAQ)
Stock Stats
News
Peer Reviewed Study Highlights Therapeutic Potential Around Application of Stromal Cell Therapies Such as INmune Bio’s CORDStrom™ Platform
INmune Bio Reports New Phase 2 Grey Matter Imaging Data at CTAD Conference Reinforcing XPro1595's Evidence Base in High-Inflammation Alzheimer's Patients [Yahoo! Finance]
INmune Bio Reports New Phase 2 Grey Matter Imaging Data at CTAD Conference Reinforcing XPro1595’s Evidence Base in High-Inflammation Alzheimer's Patients
INmune Bio Announces Two Presentations at the Upcoming 18th Annual CTAD Conference
INmune Bio (NASDAQ:INMB) was upgraded by analysts at Wall Street Zen
Form 8-K Inmune Bio, Inc. For: Dec 01
Form 8-K Inmune Bio, Inc. For: Dec 02
Form 4 Inmune Bio, Inc. For: Dec 01 Filed by: Moss David J
Form 4 Inmune Bio, Inc. For: Dec 01 Filed by: Lowdell Mark William
Form 4 Inmune Bio, Inc. For: Dec 01 Filed by: Ellspermann Cory Randall
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.